Also known as: Deforolimus; AP23573; MK-8669
Ridaforolimus is a high-purity Active Pharmaceutical Ingredient (API) classified as an mTOR Inhibitor and Antineoplastic agent. Mediocon Inc manufactures GMP-compliant Ridaforolimus at its facility in Aurangabad, Maharashtra, India for pharmaceutical supply worldwide.
| Parameter | Specification |
|---|---|
| CAS Number | 518048-05-0 |
| Molecular Formula | C₅₃H₈₄NO₁₄P |
| Molecular Weight | 990.22 g/mol |
| Grade | IP / BP / EP / USP |
| Category | mTOR Inhibitor / Antineoplastic |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | RID/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |